Berger, J. L., Smith, A., Zorn, K. K., Sukumvanich, P., Olawaiye, A. B., Kelley, J., & Krivak, T. C. (2014). Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era. Dove Medical Press.
Chicago Stili AlıntıBerger, Jessica L., Ashlee Smith, Kristin K. Zorn, Paniti Sukumvanich, Alexander B. Olawaiye, Joseph Kelley, ve Thomas C. Krivak. Outcomes Analysis of an Alternative Formulation of PEGylated Liposomal Doxorubicin in Recurrent Epithelial Ovarian Carcinoma During the Drug Shortage Era. Dove Medical Press, 2014.
MLA AlıntıBerger, Jessica L., et al. Outcomes Analysis of an Alternative Formulation of PEGylated Liposomal Doxorubicin in Recurrent Epithelial Ovarian Carcinoma During the Drug Shortage Era. Dove Medical Press, 2014.